DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions... Show more
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where DCGO declined for three days, in of 232 cases, the price declined further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on March 26, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DCGO as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The 50-day moving average for DCGO moved below the 200-day moving average on April 10, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Aroon Indicator for DCGO entered a downward trend on April 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for DCGO just turned positive on March 21, 2025. Looking at past instances where DCGO's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DCGO advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .
DCGO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.397) is normal, around the industry mean (4.616). P/E Ratio (67.250) is within average values for comparable stocks, (73.080). DCGO's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.595). DCGO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (0.683) is also within normal values, averaging (9.282).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. DCGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DCGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
Industry MedicalNursingServices
A.I.dvisor indicates that over the last year, DCGO has been loosely correlated with ORPEF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if DCGO jumps, then ORPEF could also see price increases.
Ticker / NAME | Correlation To DCGO | 1D Price Change % | ||
---|---|---|---|---|
DCGO | 100% | N/A | ||
ORPEF - DCGO | 37% Loosely correlated | N/A | ||
ASTH - DCGO | 37% Loosely correlated | N/A | ||
PNTG - DCGO | 35% Loosely correlated | -0.27% | ||
EHAB - DCGO | 35% Loosely correlated | -0.26% | ||
AVAH - DCGO | 33% Loosely correlated | -0.44% | ||
More |